Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

2.43
Delayed Data
As of Jan 13
 -0.03 / -1.22%
Today’s Change
1.51
Today|||52-Week Range
10.43
+19.12%
Year-to-Date
Why ImmnoGen, Inc. Jumped Higher Today
Jan 04 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.46
Today’s open2.47
Day’s range2.40 - 2.50
Volume980,826
Average volume (3 months)1,777,264
Market cap$212.1M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PFNXPfenex Inc+0.11+1.23%
RXDXIgnyta Inc-0.05-0.95%
CYADCelyad SA+2.66+13.99%
KMDAKamada Ltd-0.03-0.41%
Data as of 4:02pm ET, 01/13/2017

Financials

Last reporting date--
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs